Fig 1: Pan-cancer analysis of HM13 expression in TCGA. A HM13 expression in 33 types of cancers. High HM13 expression was related to overall survival and disease-free survival in patients with LGG (B) and LIHC (C)
Fig 2: Overexpressed HM13 indicated a poor prognosis for HCC. A Kaplan–Meier plots of HM13 expression in three HCC datasets. B-D Univariate and multivariate Cox regression analysis revealed that HM13 expression was an independent prognostic factor in three HCC databases
Fig 3: HM13 promoted the proliferation and migratory potential of HCC cells. A HM13 expression in four HCC cell lines. B Stable cell lines for knockdown of HM13. C CCK-8 assay. D Wound-healing assay. E Transwell assay
Fig 4: HM13 expression increased with the progression of HCC. A HM13 mRNA expression in early and later stages of HCC. B HM13 protein expression in early and later stages of HCC
Fig 5: HM13 expression was involved in immune infiltration in HCC. TIICs analysis by Timer database (A) and CIBERSORT (B)
Supplier Page from Abcam for Anti-SPP antibody